Skip to main content
. 2014 Nov 15;5(24):12753–12768. doi: 10.18632/oncotarget.2648

Table 2. AXL expression levels in primary tumors and post-chemotherapy resections.

Lesion origin AXL IHC score (n, %)
0 1 2 3 p-value1
Primary tumors (n = 15) 1 (7%) 3 (20%) 3 (20%) 8 (53%) 0.009
Post-chemotherapy resections (n = 11) 7 (64%) 2 (18%) 0 (0%) 2 (18%)
1

p-values are calculated using Fisher's exact test (contingency tables).